HHSE up 8.5% on 5x average volume after this blog from the

New Post Public Reply Private Reply Replies (1) Message Board
ds22
238
HHSE up 8.5% on 5x average volume after this blog from the company:

TO BE CLEAR: THE AUDIT PACKAGE IS DELIVERED TO OUR REPUTABLE (PCAOB CERTIFIED) AUDITORS!


BLOG: AUDIT PACKAGE DELIVERED TO REPUTABLE (PCAOB-CERTIFIED) AUDITORS!


Thursday, June 28, 2018

Delivering the HHSE Audit Package feels a bit like the final scene from "Indiana Jones"

At long last, the HHSE Audit package has been completed and has been delivered by courier today (it was "after business hours" tonight when the final alphabetizing of the file folders was completed) Some aspects of the prep for this project were relatively easy... such as the electronically delivered Quickbooks ledger of sales and payables, and scans of 1120-S filings. But other items - such as the reconciliation of producer recoupment positions for over 450 titles (many going back to 2005) - as well as the copying and collating of agreements (which averaged 12-pages per title, plus term renewals). For these more voluminous elements, a physical copy from Fedex office was more expeditious than the time that would have been required to scan, upload and download more than 4,000 pages of supporting agreements.

But it's done, and we can all now set our sights on a prompt filing of our Form 10 Registration Statement - timed to correspond with our peak consumer promotions for MYFLIX in early August.

TO BE CLEAR: THE AUDIT PACKAGE IS DELIVERED TO OUR REPUTABLE (PCAOB CERTIFIED) AUDITORS!

Stay tuned for updates! Onward & Upward!





Okay... so maybe it's not QUITE as daunting as the Indiana Jones warehouse image... but a LOT of work, copying, collating and organizing went into the completion of the HHSE audit package!





http://hannoverhousemovies.blogspot.com/2018/...s-bit.html












BLOG: MyFlix, Form-10/Audit Uplist-OTC:QB, No-Dilution, Sony/Cinedigm Partnerships, Undervalued

Friday, June 29, 2018

July looks to be a busy time for HHSE!

Happy Friday to our HHSE Friends & Followers - Corporate movements are kicking into third gear for July, with material activities on multiple fronts, and lots of meetings and travel support.

The Launch of MYFLIX requires two L.A. trips during July - plus one web-hosting visit to Seattle. The L.A. trip will also allow for some face-to-face meetings with key MYFLIX suppliers and other major studios that we are seeking to enlist. The aggressive Q3 / Q4 home video & digital release slate for the HHSE / Medallion core distribution business will also benefit from direct meetings with key wholesalers and distribution partners in the L.A. metro. And of course, we anticipate one or more day trips during July to meet with the auditors (current Form 10 project), should issues requiring clarification not be easily resolved by calls or Skype.

Hannover's original production of the Period-Thriller, THE RIOT ACT, will likely be rescheduled for theatrical release in SEPTEMBER in order to access a retail cross promotion and a College / Universities support campaign. Previously, we had planned this title for theatrical launch on Aug. 24... but the mid-to-late September date is looking more interesting. HHSE / Medallion also have two other titles for theatrical release - both planned for OCTOBER (neither acquisition has yet been announced, so out of respect for the stature of the films, the company will announce the titles via separate wire-services press releases).

With all of this exciting activity and results, some current and prospective shareholders are asking about the HHSE stock and timing. Accordingly, we share with you below the summation of notes from large traders / professional funds that have been in communication with HHSE management over the past few months.

WHY IS THIS A GREAT TIME TO LOOK AT HHSE?

1). STABILITY - Company has been in business for 25-years (since 1993).

2). DIVERSITY - Original business of BOOK PUBLISHING evolved into DVD Distribution and now into THEATRICAL and INTERNATIONAL Distribution as market conditions changed.

3). NEW MEDIA - the new MYFLIX Venture into digital streaming http://www.MyFlix.com has over 30-studio and film library participants, collectively with over 10,000 feature films and television episodic hours of entertainment. This platform will have (literally) THOUSANDS of movies not available on any other streaming site. Less than ten years ago, NETFLIX was a mail order video rental business. NOW they are among the top movers and shakers in the entertainment industry DESPITE having a very limited selection of programming for viewers. We believe that MYFLIX could be a revolutionary new streaming destination - and a massive turning point for Hannover House.

4). STOCK REGISTRATION - HHSE is currently on the "OTC-Pinksheets" exchange. This status has impeded some large, institutional investors and hedge funds from buying into the stock. However, the pending Form 10 filing (including audits), will elevate the stock to the OTC:QB status as an initial step towards possible further up-listing. The OTC:QB status will open the door to significant new shareholders, which most professional traders and investors feel will dramatically improve the PPS and trading volume for HHSE.

5). NO STOCK ISSUANCES / NO DILUTION - HHSE has not issued any new shares in the past three years, and management has repeatedly stated that there are no plans to dilute shareholders through any deals now in motion or anticipated in the future.

6). PRESENTLY UNDER-VALUED PPS - Based on the Price-Earnings ratio for other publicly traded film / entertainment distributors, HHSE should be enjoying a 22X share price based on earnings. HHSE is on target to realize $1,250,000 in earnings for FYE 12-31-2018. This supports a share price of $.034 at present... and does not take into account the tremendous good-will and enthusiasm factor for the upcoming launch of MyFlix. Some highly respected stock analysts have communicated to HHSE management their prediction that the company's activities could support a share price of $.15 - which is more than ten-times current pricing. Even if their predictions are off by 75% - there is still an easily justifiable share price that is many times more than current trading levels.

7). TIMING-TIMING-TIMING - The launch of Myflix is a "second generation" site, in that the digital streaming technology and consumer acceptance have already been established. With that essential battle already won, MyFlix can concentrate on becoming "the better mousetrap" for digital entertainment. You combine this ideal market timing with the company's stock registration uplist, the presence of significant new shareholders post-registration, and new distribution pacts for the company's core film distribution activities (SONY / CINEDIGM), many feel that NOW is the ideal time to take a position in HHSE shares (while the HHSE Price Per Share is artificially low). Are these professional traders right? We will all know very soon!

HHSE makes no representation, guarantee or warranty that our share price will improve significantly as a result of these and other current activities. Every stock investment involves risks and factors outside of the control of issuers and management. But we proudly share with you the above information, projections and rationale' that professional traders have identified as the basis for why they believe that NOW is a great time to look at HHSE.

CHECK THIS BLOG SITE FOR REGULAR UPDATES ON HHSE and MYFLIX!


http://hannoverhousemovies.blogspot.com/2018/...-hhse.html


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harrison Street & Aegis Living's Strategic Venture Kick-Off

Updated Category News Views 49

New Alliance in Senior Living: Aegis and Harrison Street Team Up Here's something that caught my eye—two heavy hitters in the senior living sector joining forces for what they're calling a strategic joint venture. Harrison Street, known for its real estate investments with a flair for large-scale projects, has shaken hands with Aegis Living, a name synonymous with...

Continue Reading
Attilio's Longevity Push: Science with a Personal Touch

Updated Category News Views 88

Reimagining Longevity: Beyond Just Adding Years Guess what? Living longer isn't just about reaching the milestone of blowing out 100 birthday candles. That's the message Attilio drilled home during their recent Longevity Event. And let me tell you, it was quite a doozy—from what went down at Stanford to a deep dive at the Buck Institute, it was an eye-opening affair....

Continue Reading
Hanon Systems Reports 2026 Q3 Results: Profit Soars

Updated Category News Views 102

Profit Surges Despite Revenue Dip When a company's profit jumps up while sales take a slight nosedive, they're doing something right—or maybe they've got a lucky rabbit's foot. Hanon Systems just rolled out their numbers for Q3 2026, and here's what's cooking: operating profit soared a whopping 26.6% year-on-year to hit KRW 120.6 billion, even while revenue stumbled a...

Continue Reading
Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 105

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 24

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Curis Prepares for Q3 2026 Results Amid Tough Sector Trends

Updated Category News Views 139

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

Continue Reading
MCAP's Q3 Earnings: Sizing Up the Tech Game

Updated Category News Views 102

Quarterly Results: The Numbers to Watch Alright, here's the scoop from MCAP Inc.: they just tossed their hat in the quarterly earnings ring, flexing a third quarter EPS of $0.15 a share. Not exactly champagne-popping numbers, but hey, let's not throw out the party favors just yet. Revenues rolled in at a neat $26.7 million, with EBITDA tagging along at $5.2 million. So,...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 41

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Amy Aceto-Hitchinson: A Force in Nonprofit Innovation

Updated Category News Views 122

A Visionary in Nonprofit Leadership Inner Circle honoring Amy Aceto-Hitchinson? Now that's some spotlight, and for good reason. Her work isn't just a footnote in nonprofit circles; it's the headline. She's reshaped the early childhood development space with the finesse of an investment titan who's got decades under her belt in real estate and international partnerships....

Continue Reading
3D Systems Faces Scrutiny Over Earnings Report

Updated Category News Views 70

3D Systems' Earnings Leave Investors on Edge Like a hot potato, 3D Systems’ latest earnings report has investors feeling jittery. And with good reason–their third-quarter numbers are a mixed bag as they somehow squeezed out a positive $3.1 million in adjusted EBITDA and yet posted a yawning $33.5 million GAAP net loss. No wonder heads are spinning over at SueWallSt,...

Continue Reading

Top 5 Most Recently Viewed Articles

Aspire Revolutionizes Ads with CreatorAds Suite Launch

Updated Category News Views 288

Aspire Revolutionizes Advertising with CreatorAds Suite In an era where digital marketing is rapidly evolving, Aspire is taking significant strides by introducing a game-changing upgrade to its advertising capabilities. With the launch of the CreatorAds Suite, brands now possess the tools to create ads, establish campaign goals, budgets, targeting, and monitor both...

Continue Reading
Innovations in AI and NEVs Shine at Global Industry Expo

Updated Category News Views 182

Exciting Developments Unveiled at the World Smart Industry Expo The World Smart Industry Expo kicked off recently in China, and it is the highlight of technological advancements, focusing on the fusion of Artificial Intelligence (AI) and new energy vehicles (NEVs). This year's event sees participation from over 550 companies showcasing a remarkable array of innovations...

Continue Reading
Strategies Driving Growth in Embedded Finance Market

Updated Category News Views 140

Embedded Finance Market Overview In today's fast-paced financial landscape, the embedded finance market is capturing attention as it undergoes a significant transformation. This market, valued at approximately $82.7 billion, is projected to expand to around $570.9 billion by 2033, growing at an impressive compound annual growth rate (CAGR) of 21.3% from 2024 to 2033. The...

Continue Reading
Kingsoft Cloud Unveils Upcoming Financial Results Announcement

Updated Category News Views 116

Kingsoft Cloud to Announce Financial Results for 2024 Kingsoft Cloud Holdings Limited (NASDAQ: KC), a prominent cloud service provider in China, is set to unveil its unaudited financial results for the fourth quarter and fiscal year 2024. The announcement will occur before the opening of U.S. markets on an anticipated morning in late March. Details of the Financial...

Continue Reading
Legal Inquiry into Capricor Therapeutics Actions for Investors

Updated Category News Views 195

Capricor Therapeutics Under Investigation Faruqi & Faruqi, LLP, a recognized leader in securities law, is currently undertaking an investigation regarding claims for investors associated with Capricor Therapeutics Inc. If you're among those who sustained significant losses in your investment, particularly exceeding $50,000, it’s vital that you seek guidance about the...

Continue Reading